|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ChiCTR |
|
Last refreshed on:
|
19 February 2018 |
|
Main ID: |
ChiCTR1800014909 |
|
Date of registration:
|
2018-02-17 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Wet-Wrap Therapy for Severe Adult Atopic Dermatitis
|
|
Scientific title:
|
Wet-Wrap Therapy for Severe Adult Atopic Dermatitis |
|
Date of first enrolment:
|
2018-02-18 |
|
Target sample size:
|
treatment:12; |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=25438 |
|
Study type:
|
Observational study |
|
Study design:
|
Case series
|
|
Phase:
|
New Treatment Measure Clinical Study
|
|
|
Countries of recruitment
|
|
China
| | | | | | | |
|
Contacts
|
|
Name:
|
Xu Wei
|
|
Address:
|
95 Yong'an Road, Xicheng District, Beijing, China
100050
|
|
Telephone:
|
+86 18611015100 |
|
Email:
|
2403649155@qq.com |
|
Affiliation:
|
Department of Dermatology, Beijing Friendship Hospital, Capital Medical University |
|
|
Name:
|
Li Linfeng
|
|
Address:
|
95 Yong'an Road, Xicheng District, Beijing, China
100050
|
|
Telephone:
|
+86 010 63138425 |
|
Email:
|
zoonli@sina.com |
|
Affiliation:
|
Department of Dermatology, Beijing Friendship Hospital, Capital Medical University |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: 1) diagnosed with AD according to the Williams criteria [11] and had a SCORing Atopic Dermatitis (SCORAD) score =50; 2) age >18 years;
3) except oral antihistamine, patients did not receive any other systematic treatments for AD 1 month before the enrolment;
4) signed the informed consent form.
Exclusion criteria: 1) had secondary viral, bacterial, and/or fungal infections in the skin lesions;
2) had malignancy, autoimmune diseases, severe systematic infectious diseases, mental diseases, and/or serious diseases in liver, kidney, and/or vascular system;
3) were allergic to halometasone cream or Vaseline ointment;
4) with poor compliance to the study protocol.
Age minimum:
18
Age maximum:
90
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Atopic dermatitis
|
|
Intervention(s)
|
|
treatment:Wet Wrap Theray;
|
|
Primary Outcome(s)
|
|
The Scoring Atopic Dermatitis (SCORAD) score;
|
|
Secondary Outcome(s)
|
|
investigator’s global assessment (IGA) score;dermatology life quality index (DLQI) score;visual analogue scale (VAS);
|
|
Source(s) of Monetary Support
|
|
self-financing
|
|
Ethics review
|
Status: Approved
Approval date: 24/11/2017
Contact:
13661202501@163.com
Li Yue
+86 13661202501
13661202501@163.com
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|